로딩 중…
지수 로딩 중…
Nkarta, Inc.
NKTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$2.15+2.87%
2026-08-03
Financials
Valuation Metrics
Nkarta, Inc.'s Market Cap is $154M. At end of 2025 it was $137M. Ranked #3055 of 3,112 in US market (top 98%), #1398 of 1,445 on NASDAQ (top 97%), #262 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 97%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $154M | US#3,055/3,112 Sec#262/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-100M | US—/3,112 Sec—/269 |
| Total Assets | $372M | US#2,846/3,112 Sec#191/269 |
| Net Assets | $286M | US#2,570/3,112 Sec#161/269 |
| Value | ||
| P/B | 0.54x | US#78/3,112 Sec#1/269 |
| FCF Yield | -57.46% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -34.96% | US#2,653/3,112 Sec#137/269 |
| ROA | -26.86% | US#2,843/3,112 Sec#151/269 |
| Financial Health | ||
| Debt Ratio | 30.16% | US#337/3,112 Sec#107/269 |
| Total Debt | $75M | US#2,454/3,112 Sec#133/269 |
| FCF | $-88M | US#2,567/3,112 Sec#143/269 |
| Cash | $27M | US#2,790/3,112 Sec#253/269 |
| Current Ratio | 12.96x | US#189/3,112 Sec#65/269 |
| Performance | ||
| 1Y Return | 1.42% | US#2,034/3,112 Sec#190/269 |
| 1M Return | -33.23% | US#3,080/3,112 Sec#260/269 |
| From 52W High | -42.20% | US#2,604/3,112 Sec#202/269 |
| 1Y MDD | -43.05% | US#2,102/3,112 Sec#155/269 |
| Trading | ||
| Volume | 608,755 shares | US#1,915/3,112 Sec#187/269 |
| Trading Value | $1M | US#2,996/3,112 Sec#252/269 |
| Per Share | ||
| EPS | $-1.04 | US—/3,112 Sec—/269 |
| BPS | $4.56 | US#2,267/3,112 Sec#138/269 |